Canine cancer vaccine in development could see wide distribution

02/28/2012 | FloridaTrend.com

Florida-based company Morphogenesis developed a canine lymphoma cell-processing treatment, a process in which tumor cells become a target for the immune system by being labeled with a bacterial protein. Researchers at Morphogenesis are now developing a vaccine from stock cells instead of using a patient's own tumor cells, which could allow the treatment to become widely available.

View Full Article in:

FloridaTrend.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Children's Health Plan
Houston, TX